Post

New research · Ophthalmology
Journal of contemporary brachytherapy · 16h
ReviewJournal of contemporary brachytherapy · 2025

High-dose-rate brachytherapy for eyelid carcinoma: Implant technique and review.

Jose Luis Guinot, Cristina Gutierrez, Mar Vercher … Dina Najjari
Read paper
OphthalmologyReview

High-dose rate brachytherapy for eyelid carcinoma achieves local control above 94%.

High-dose-rate brachytherapy for eyelid carcinoma: Implant technique and review.

Jose Luis Guinot … Dina Najjari
Journal of contemporary brachytherapy · 2025
Background

Eyelid carcinoma is a tumor often detected at an early stage, which can be managed surgically.

94%
Results
94%
tumor stayed controlled without regrowth in nearly all patients treated
More results

In non-surgical cases, brachytherapy is a valid alternative or as adjuvant therapy when risk factors exist.

Basal cell carcinoma is the most common type of eyelid cancer, usually occurring in the lower eyelid.

Interstitial technique with plastic tubes is a simple procedure in this location.

More results

This article provided practical description of the technique and review of literature.

“
Conclusion

Collaboration between ophthalmology, dermatology, and brachytherapy specialists is essential to achieve the best patient outcomes.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving